Moreover, studies on transgenic mouse models of AD indicated that high cholesterol levels can increase AD-pathology hallmarks such as amyloid levels, Tau phosphorylation, and behavioral deficits [33, 35, 37]. Here, MAPT is linked to Alzheimer disease.